Attentional Mechanisms in SCD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Attentional Mechanisms in SCD — Stella

Home/Subjective Cognitive Decline/

View on ClinicalTrials.gov

Recruiting

Back to Subjective Cognitive Decline trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Phase

Very early testing

Sponsor

Vanderbilt University Medical Center

Enrollment target

~80 participants

Started

March 2025

Primary completion

June 2028

Age range

55 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.